sivelestat has been researched along with Idiopathic Interstitial Pneumonia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ando, K; Fukui, M; Matsunaga, T; Oh, S; Suzuki, K; Takamochi, K | 1 |
| Ito, H; Nakayama, H; Yamada, K; Yokose, T | 1 |
2 trial(s) available for sivelestat and Idiopathic Interstitial Pneumonia
| Article | Year |
|---|---|
Study on Perioperative Administration of a Neutrophil Elastase Inhibitor for Interstitial Pneumonias.
Topics: Aged; Biomarkers; Female; Glycine; Humans; Idiopathic Interstitial Pneumonias; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; Perioperative Care; Pneumonectomy; Postoperative Complications; Prospective Studies; Proteinase Inhibitory Proteins, Secretory; Secondary Prevention; Sulfonamides; Survival Analysis | 2017 |
Prophylaxis for acute exacerbation of interstitial pneumonia after lung resection.
Topics: Aged; Aged, 80 and over; Anesthesia, General; Carcinoma, Non-Small-Cell Lung; Drug Administration Schedule; Female; Glucocorticoids; Glycine; Humans; Idiopathic Interstitial Pneumonias; Infusions, Intravenous; Injections, Intravenous; Japan; Lung Neoplasms; Male; Methylprednisolone; Middle Aged; Pilot Projects; Pneumonectomy; Preoperative Care; Prospective Studies; Risk Factors; Serine Proteinase Inhibitors; Sulfonamides; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2014 |